_8513138041767195205

2010 publication year MI:0886, 7 last-imex-assigned, Anti-RAR-alpha antibody used. antibodies MI:0671, Cancer - Interactions investigated in the context of cancer dataset MI:0875, Cancer Cell (1535-6108) journal MI:0885, Only protein-protein interactions full coverage MI:0957, PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia., Re-chIp assay using ZnSO4-treated PR9 cells. exp-modification MI:0627, TrEMBL Q15156 (PML-RAR fusion protein)has been used as a reference entry only, as the exact sequence of the fusion protein is not known. comment MI:0612, Wang K., Wang P., Shi J., Zhu X., He M., Jia X., Yang X., Qiu F., Jin W., Qian M., Fang H., Mi J., Yang X., Xiao H., Minden M., Du Y., Chen Z., Zhang J. author-list MI:0636, imex curation MI:0959, imex curation curation depth MI:0955, jizhang@sibs.ac.cn contact-email MI:0634

HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_5811872405064717358, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_3506680204208502563